SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics

Benzinga
2025.09.16 13:09
portai
I'm PortAI, I can summarize articles.

West Conshohocken, PA, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- SERB Pharmaceuticals ( "SERB" ) , a global specialty pharmaceutical company focused on rare diseases and medical emergencies, today announced the successful completion of its acquisition of Y-mAbs Therapeutics, Inc. ( "Y-mAbs" ) , a ...

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer